Previous 10 | Next 10 |
2024-06-05 11:34:16 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation Jazz Pharmaceuticals: Cheap But Complicated Jazz presents additional p...
2024-06-05 05:00:07 ET Andrea Tan from Goldman Sachs issued a price target of $169.00 for JAZZ on 2024-06-05 02:23:00. The adjusted price target was set to $169.00. At the time of the announcement, JAZZ was trading at $104.48. The overall price target consensus is at $20...
2024-06-01 17:13:06 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (u...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 PR Newswire Zanidatamab demonstrated a median overall survival (OS) of 15.5 month...
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 PR Newswire Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral ...
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire DUBLIN , May 29, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences...
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Target Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ ...
2024-05-26 10:09:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many ar...
Originally published by Jazz Pharmaceuticals DUBLIN, IRELAND / ACCESSWIRE / May 22, 2024 / Jazz Pharmaceuticals plc (Nasdaq:JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in the United States. This partnership rei...
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism PR Newswire DUBLIN , May 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a ...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance PR Newswire – 15% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – O...
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting PR Newswire Ms. Hamill brings extensive experience and proven leadership focused on commercial growth and shareholder value DUBLIN , July 25, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals In celebration of Pride Month , we were joined by Celia Sandhya Daniels (she/they) who led an insightful discussion aimed at educating, raising awareness and calling for unders...